Assessments

A medicine distributor stores Mounjaro (tirzepatide) self-injecting GLP-1 prefilled pens and vials in a fridge at his office in Thane, India, on March 20, 2026. 

India's pharmaceutical and medical technology sectors are set to grow significantly over the next several years amid manufacturing incentives, regulatory reforms and trade deals.

The Growth Outlook for India's Pharmaceutical Sector Remains Strong, Despite Global Uncertainties

Highlights

United States

Iran

Kuwait

Oman

Saudi Arabia

United Arab Emirates

Yemen

Europe

India

Economics

Environment, Science & Technology

Politics

Despite ongoing global trade and energy uncertainties, India's pharmaceutical and medical technology sectors are set to experience strong growth driven by manufacturing incentives, regulatory reforms and improved access to foreign markets, although supply-chain vulnerabilities, reliance on imported APIs and U.S. trade investigations pose risks of production disruptions, export delays and market volatility. 

ASSESSMENTS

The Growth Outlook for India's Pharmaceutical Sector Remains Strong, Despite Global Uncertainties

Subscribe to view this article